NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 48 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $57,535 | -2.7% | 311,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $59,152 | -51.9% | 311,000 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $123,000 | -62.4% | 311,000 | 0.0% | 0.00% | -55.6% |
| Q2 2022 | $327,000 | -44.1% | 311,000 | 0.0% | 0.01% | -47.1% |
| Q1 2022 | $585,000 | -33.1% | 311,000 | 0.0% | 0.02% | -22.7% |
| Q4 2021 | $874,000 | -22.2% | 311,000 | 0.0% | 0.02% | -24.1% |
| Q3 2021 | $1,123,000 | -24.6% | 311,000 | 0.0% | 0.03% | -34.1% |
| Q2 2021 | $1,490,000 | -35.2% | 311,000 | 0.0% | 0.04% | -25.4% |
| Q1 2021 | $2,298,000 | +5.7% | 311,000 | 0.0% | 0.06% | +7.3% |
| Q4 2020 | $2,174,000 | – | 311,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 906,445 | $3,272,000 | 1.04% |
| Greenlight Capital | 2,727,027 | $9,844,000 | 0.66% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 407,500 | $1,471,000 | 0.54% |
| CM Management, LLC | 75,000 | $271,000 | 0.20% |
| Stonepine Capital Management, LLC | 109,742 | $396,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 351,178 | $1,268,000 | 0.13% |
| PERKINS CAPITAL MANAGEMENT INC | 21,000 | $76,000 | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $1,123,000 | 0.03% |
| Polar Asset Management Partners Inc. | 634,618 | $2,291,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,250,000 | $4,513,000 | 0.02% |